BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1682923)

  • 1. Chronic myeloproliferative disease induced by site-specific integration of Abelson murine leukemia virus-infected hemopoietic stem cells.
    Han XD; Wong PM; Chung SW
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10129-33. PubMed ID: 1682923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia initiated by hemopoietic stem cells expressing the v-abl oncogene.
    Chung SW; Wong PM; Durkin H; Wu YS; Petersen J
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1585-9. PubMed ID: 1996361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. v-abl causes hematopoietic disease distinct from that caused by bcr-abl.
    Scott ML; Van Etten RA; Daley GQ; Baltimore D
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6506-10. PubMed ID: 1862078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.
    Kelliher MA; McLaughlin J; Witte ON; Rosenberg N
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6649-53. PubMed ID: 2204061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of quiescent ABL-transduced hemopoietic stem cells.
    Chung SW; Chen H; Wong PM
    Oncogene; 1996 Dec; 13(11):2397-405. PubMed ID: 8957081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple steps are required for the induction of tumors by Abelson murine leukemia virus.
    Green PL; Kaehler DA; Bennett LM; Risser R
    J Virol; 1989 May; 63(5):1989-94. PubMed ID: 2539498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moloney murine leukemia virus-induced myeloid tumors in adult BALB/c mice: requirement of c-myb activation but lack of v-abl involvement.
    Shen-Ong GL; Wolff L
    J Virol; 1987 Dec; 61(12):3721-5. PubMed ID: 2824810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blast colonies containing hemopoietic progenitor cells can give rise to Abelson virus (A-MuLV)-transformed cell lines.
    Wong PM; Chung SW; Raefsky E; Eaves CJ; Nienhuis AW
    Exp Hematol; 1988 Jan; 16(1):5-11. PubMed ID: 2446900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus.
    Marchlik E; Kalman R; Rosenberg N
    J Virol; 2005 Sep; 79(18):11618-26. PubMed ID: 16140739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of Abelson murine leukemia virus target cells.
    Waneck GL; Rosenberg N
    Haematol Blood Transfus; 1981; 26():467-71. PubMed ID: 6274760
    [No Abstract]   [Full Text] [Related]  

  • 11. Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.
    Holland GD; Henkemeyer MJ; Kaehler DA; Hoffmann FM; Risser R
    J Virol; 1990 May; 64(5):2226-35. PubMed ID: 2157882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxyl-terminal determinants of Abelson protein important for lymphoma induction.
    Parmar K; Huebner RC; Rosenberg N
    J Virol; 1991 Dec; 65(12):6478-85. PubMed ID: 1942244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of flat revertants isolated from cells transformed by Abelson murine leukemia virus (Ab-MuLV).
    Oka T; Yutsudo M; Inoue H; Higuchi F; Hakura A
    J Cell Physiol; 1990 Dec; 145(3):428-33. PubMed ID: 1703165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA.
    Poirier Y; Kozak C; Jolicoeur P
    J Virol; 1988 Nov; 62(11):3985-92. PubMed ID: 2845118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complexity of virus--cell interactions in Abelson virus infection of lymphoid and other hematopoietic cells.
    Whitlock CA; Witte ON
    Adv Immunol; 1985; 37():73-98. PubMed ID: 2988306
    [No Abstract]   [Full Text] [Related]  

  • 16. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus.
    Hawley RG; Fong AZ; Burns BF; Hawley TS
    J Exp Med; 1992 Oct; 176(4):1149-63. PubMed ID: 1402659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes.
    Clark SS; Liang Y; Reedstrom CK; Wu SQ
    Blood; 1994 Dec; 84(12):4301-9. PubMed ID: 7994046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice.
    Gishizky ML; Johnson-White J; Witte ON
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3755-9. PubMed ID: 8475126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of v-abl oncogene induces monocytic differentiation of an IL-3-dependent myeloid progenitor cell line.
    Keller JR; Ruscetti SK; Ruscetti FW
    Oncogene; 1990 Apr; 5(4):549-55. PubMed ID: 2158039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis.
    Green PL; Kaehler DA; Risser R
    J Virol; 1987 Jul; 61(7):2192-7. PubMed ID: 3035219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.